Literature DB >> 25261112

Epigenetic mechanisms underlying the pathogenesis of neurogenetic diseases.

Irfan A Qureshi1, Mark F Mehler.   

Abstract

There have been considerable advances in uncovering the complex genetic mechanisms that underlie nervous system disease pathogenesis, particularly with the advent of exome and whole genome sequencing techniques. The emerging field of epigenetics is also providing further insights into these mechanisms. Here, we discuss our understanding of the interplay that exists between genetic and epigenetic mechanisms in these disorders, highlighting the nascent field of epigenetic epidemiology-which focuses on analyzing relationships between the epigenome and environmental exposures, development and aging, other health-related phenotypes, and disease states-and next-generation research tools (i.e., those leveraging synthetic and chemical biology and optogenetics) for examining precisely how epigenetic modifications at specific genomic sites affect disease processes.

Entities:  

Mesh:

Year:  2014        PMID: 25261112      PMCID: PMC4391378          DOI: 10.1007/s13311-014-0302-1

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  144 in total

1.  Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations.

Authors:  Frank Soldner; Josée Laganière; Albert W Cheng; Dirk Hockemeyer; Qing Gao; Raaji Alagappan; Vikram Khurana; Lawrence I Golbe; Richard H Myers; Susan Lindquist; Lei Zhang; Dmitry Guschin; Lauren K Fong; B Joseph Vu; Xiangdong Meng; Fyodor D Urnov; Edward J Rebar; Philip D Gregory; H Steve Zhang; Rudolf Jaenisch
Journal:  Cell       Date:  2011-07-14       Impact factor: 41.582

Review 2.  Targeting bromodomains: epigenetic readers of lysine acetylation.

Authors:  Panagis Filippakopoulos; Stefan Knapp
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

3.  Myogenic enhancers regulate expression of the facioscapulohumeral muscular dystrophy-associated DUX4 gene.

Authors:  Charis L Himeda; Céline Debarnot; Sachiko Homma; Mary Lou Beermann; Jeffrey B Miller; Peter L Jones; Takako I Jones
Journal:  Mol Cell Biol       Date:  2014-03-17       Impact factor: 4.272

4.  Dynamics and memory of heterochromatin in living cells.

Authors:  Nathaniel A Hathaway; Oliver Bell; Courtney Hodges; Erik L Miller; Dana S Neel; Gerald R Crabtree
Journal:  Cell       Date:  2012-06-14       Impact factor: 41.582

5.  Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.

Authors:  Emily S Wan; Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Helene Bacherman; Stephen I Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L Demeo
Journal:  Hum Mol Genet       Date:  2012-04-06       Impact factor: 6.150

6.  Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Authors:  Dilek Colak; Nikica Zaninovic; Michael S Cohen; Zev Rosenwaks; Wang-Yong Yang; Jeannine Gerhardt; Matthew D Disney; Samie R Jaffrey
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

7.  Disruption of a large intergenic noncoding RNA in subjects with neurodevelopmental disabilities.

Authors:  Michael E Talkowski; Gilles Maussion; Liam Crapper; Jill A Rosenfeld; Ian Blumenthal; Carrie Hanscom; Colby Chiang; Amelia Lindgren; Shahrin Pereira; Douglas Ruderfer; Alpha B Diallo; Juan Pablo Lopez; Gustavo Turecki; Elizabeth S Chen; Carolina Gigek; David J Harris; Va Lip; Yu An; Marta Biagioli; Marcy E Macdonald; Michael Lin; Stephen J Haggarty; Pamela Sklar; Shaun Purcell; Manolis Kellis; Stuart Schwartz; Lisa G Shaffer; Marvin R Natowicz; Yiping Shen; Cynthia C Morton; James F Gusella; Carl Ernst
Journal:  Am J Hum Genet       Date:  2012-12-07       Impact factor: 11.025

Review 8.  DNA methylation profiling in the clinic: applications and challenges.

Authors:  Holger Heyn; Manel Esteller
Journal:  Nat Rev Genet       Date:  2012-09-04       Impact factor: 53.242

9.  Genome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus.

Authors:  Reid S Alisch; Tao Wang; Pankaj Chopra; Jeannie Visootsak; Karen N Conneely; Stephen T Warren
Journal:  BMC Med Genet       Date:  2013-01-29       Impact factor: 2.103

10.  Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.

Authors:  A Vaishnavi; M Capelletti; P A Jänne; R C Doebele; A T Le; S Kako; M Butaney; D Ercan; S Mahale; K D Davies; D L Aisner; A B Pilling; E M Berge; J Kim; H Sasaki; S Park; G Kryukov; L A Garraway; Peter S Hammerman; J Haas; S W Andrews; D Lipson; P J Stephens; V A Miller; M Varella-Garcia
Journal:  Nat Med       Date:  2013-10-27       Impact factor: 53.440

View more
  8 in total

1.  Neurogenetic disease: genes, mechanisms, and future promise.

Authors:  William T Dauer
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 2.  Epigenetic mechanisms underlying nervous system diseases.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Handb Clin Neurol       Date:  2018

Review 3.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

Review 4.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

Review 5.  Epigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based Models.

Authors:  Rubén Fernández-Santiago; Mario Ezquerra
Journal:  Stem Cells Int       Date:  2015-11-30       Impact factor: 5.443

Review 6.  Getting into the brain: liposome-based strategies for effective drug delivery across the blood-brain barrier.

Authors:  Débora B Vieira; Lionel F Gamarra
Journal:  Int J Nanomedicine       Date:  2016-10-18

Review 7.  Epigenetics and cerebral organoids: promising directions in autism spectrum disorders.

Authors:  Sheena Louise Forsberg; Mirolyuba Ilieva; Tanja Maria Michel
Journal:  Transl Psychiatry       Date:  2018-01-10       Impact factor: 6.222

8.  The neuroprotective action of 3,3'-diindolylmethane against ischemia involves an inhibition of apoptosis and autophagy that depends on HDAC and AhR/CYP1A1 but not ERα/CYP19A1 signaling.

Authors:  J Rzemieniec; A Wnuk; W Lasoń; W Bilecki; M Kajta
Journal:  Apoptosis       Date:  2019-06       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.